In 10 seconds? Researchers are tackling HPV-associated cancers with new, so-called ‘living’ cancer treatments. These engineered T-cell receptors make a patient’s immune cells target HPV proteins in tumors and suppress the cancer.
Hey, I thought the vaccine was successful in preventing HPV-associated cancers? Well, yes, but the vaccine is relatively new so many older people couldn't benefit from it and might have the misfortune of developing an HPV-associated cancer (like cervical, anal, and head and neck cancer). That's why researchers continue the search for better treatments for patients with these cancers.
Try our 7-day free trial and access the full article with citations and resources.